BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 27273018)

  • 1. Emerging hepatic syndromes: pathophysiology, diagnosis and treatment.
    Bertino G; Privitera G; Purrello F; Demma S; Crisafulli E; Spadaro L; Koukias N; Tsochatzis EA
    Intern Emerg Med; 2016 Oct; 11(7):905-16. PubMed ID: 27273018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of ascites and hepatorenal syndrome.
    Piano S; Tonon M; Angeli P
    Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
    Wong F; Pantea L; Sniderman K
    Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatorenal syndrome.
    Biswas KD; Jain AK
    Trop Gastroenterol; 2002; 23(3):113-6. PubMed ID: 12693150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The modern possibilities of the hepato-renal syndrome treatment].
    Blokhina NV; Pasechnik IN
    Khirurgiia (Mosk); 2013; (8):81-5. PubMed ID: 24344429
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute kidney injury and hepatorenal syndrome in cirrhosis.
    Egerod Israelsen M; Gluud LL; Krag A
    J Gastroenterol Hepatol; 2015 Feb; 30(2):236-43. PubMed ID: 25160511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Physiopathology of refractory ascites and the hepatorenal syndrome].
    Arroyo V
    Nefrologia; 2002; 22 Suppl 5():41-6. PubMed ID: 12107916
    [No Abstract]   [Full Text] [Related]  

  • 8. Current management of the complications of portal hypertension: variceal bleeding and ascites.
    Dib N; Oberti F; Calès P
    CMAJ; 2006 May; 174(10):1433-43. PubMed ID: 16682712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatorenal syndrome: diagnosis, treatment and prevention].
    Egerod Israelsen M; Gluud LL; Bendtsen F; Møller S; Krag AA
    Ugeskr Laeger; 2013 May; 175(22):1562-6. PubMed ID: 23721840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Update on hepatorenal syndrome].
    Blaise P; Moonen M; Rorive G
    Nephrologie; 2002; 23(1):11-7. PubMed ID: 11887572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome.
    Arroyo V; Terra C; Ginès P
    J Hepatol; 2007 May; 46(5):935-46. PubMed ID: 17391801
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of ascites in patients with liver cirrhosis: recent evidence and controversies.
    Hsu SJ; Huang HC
    J Chin Med Assoc; 2013 Mar; 76(3):123-30. PubMed ID: 23497963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midodrine and octreotide in treatment of cirrhosis-related hemodynamic complications.
    Karwa R; Woodis CB
    Ann Pharmacother; 2009 Apr; 43(4):692-9. PubMed ID: 19299324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome.
    Krag A; Borup T; Møller S; Bendtsen F
    Adv Ther; 2008 Nov; 25(11):1105-40. PubMed ID: 19018483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatorenal syndrome.
    Kramer L; Hörl WH
    Semin Nephrol; 2002 Jul; 22(4):290-301. PubMed ID: 12118394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of hepatorenal syndrome.
    Carl DE; Sanyal A
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):207-26. PubMed ID: 19305378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute Kidney Injury in Cirrhotic Patients with Portal Hypertension].
    Kim SM; Song IH
    Korean J Gastroenterol; 2016 Nov; 68(5):237-244. PubMed ID: 27871159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting circulatory dysfunction in cirrhosis: terlipressin and the hepatorenal syndrome.
    Testro AG; Angus PW
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1707-9. PubMed ID: 20136956
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatorenal syndrome.
    Cárdenas A; Arroyo V
    Ann Hepatol; 2003; 2(1):23-9. PubMed ID: 15094702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.